 |
|
| The Annual European Congress of Rheumatology was held in Nice, France from June 21-24, 2000. this is the official meeting of the European Leagure Against Rheumatism (EULAR). One thousand (1000) scientific abstracts were submitted for the meeting, and 80% of these were accepted for presentation. Only 5% of these were podium presentations; the remainder were presented in poster format. Full abstract reports may be reviewed in the July edition of Annals of the Rheumatic Diseases 59, no. 1 suppl., 2000. While it is not possible to review all of the important findings from these meetings, some selected highlights are summarized below. The majority of these highlights focus on diseases whose predominant manifestation is arthritis (consistent with the mission of this WebSite). The highlights are summarized by Joan Bathon, M.D. and Jane McKenzie White, website project manager. |
 |
Rheumatoid
Arthritis-Treatments |
TNF Inhibitors
Interleukin-1 receptor antagonist
Leflunomide
Cyclosporin
Animal Studies
|
 |
Rheumatoid
Arthritis-Basic Science |
Interleukin-17
Cartilage Degradation
Interleukin-1 Recepor Antagonist
Flice Inhibitory Protein
CXCRC Receptor
|
 |
Rheumatoid
Arthritis-Diagnostic Criteria |
Early RA
|
 |
Osteoarthritis-Treatments |
COX-2 Inhibitors
|
 |
Osteoarthritis-Management Guidelines |
ACR-OA of the Hip and Knee
EULAR-OA of the Knee
|
 |
Osteoporosis |
Alendronate
|
All
information contained within the Johns Hopkins Arthritis Center website
is intended for educational purposes only. Physicians and other health care
professionals are encouraged to consult other sources and confirm the information
contained within this site. Consumers should never disregard medical advice
or delay in seeking it because of something they may have read on this website. 
|